Evidence map›Paper›PMID 25706537›Full record

ArticlePloS one2015

A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination.

Kristen L Hoek, Parimal Samir, Leigh M Howard, Xinnan Niu, Nripesh Prasad, Allison Galassie, Qi Liu, Tara M Allos, Kyle A Floyd, Yan Guo and 5 more

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Proteomic Analysis of Cancer-Related Alterations in the Human Unfoldome.International journal of molecular sciences · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Kristen L HoekDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Parimal SamirDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Leigh M HowardVanderbilt Vaccine Research Program; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Xinnan NiuDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Nripesh PrasadHudsonAlpha Institute for Biotechnology, Huntsville, AL, 35806, United States of America.
Allison GalassieDepartment of Chemistry, Vanderbilt University, Nashville, TN, 27232, United States of America.
Qi LiuDepartment of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Tara M AllosDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Kyle A FloydDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Yan GuoDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Yu ShyrDepartment of Cancer Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Shawn E LevyHudsonAlpha Institute for Biotechnology, Huntsville, AL, 35806, United States of America.
Sebastian JoyceDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Kathryn M EdwardsVanderbilt Vaccine Research Program; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.
Andrew J LinkDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, 37232, United States of America.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
Childhood Infections Research ProgramT32AI095202 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JAMES E CASSAT · 2011 to 2026
$4.2M
Proteomic Analysis of Eukaryotic Protein SynthesisR01GM064779 · NIGMS · VANDERBILT UNIVERSITY · PI LINK, ANDREW J. · 2002 to 2010
$3.0M
Processing and Presentation of Minor Histocompatibility Antigens that Cause GvHDR01HL121139 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JOYCE, SEBASTIAN · 2014 to 2017
$1.6M
Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and AdjuvantI01BX001444 · VA · VETERANS HEALTH ADMINISTRATION · PI JOYCE, SEBASTIAN · 2014 to 2022
–
BLRD VA I01 BX001444NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCRR NIH HHS RR024975NCRR NIH HHS UL1 RR024975NHLBI NIH HHS 5 T32 HL69765-12NHLBI NIH HHS R01 HL121139NHLBI NIH HHS T32 HL069765NIAID NIH HHS T32 AI095202NIAID NIH HHS T32-AI095202-01NIDDK NIH HHS DK058404NIDDK NIH HHS P30 DK058404NIGMS NIH HHS GM064779NIGMS NIH HHS R01 GM064779PHS HHS 272200800007C
6 · The paper itself

Abstract

Systems biology is an approach to comprehensively study complex interactions within a biological system. Most published systems vaccinology studies have utilized whole blood or peripheral blood mononuclear cells (PBMC) to monitor the immune response after vaccination. Because human blood is comprised of multiple hematopoietic cell types, the potential for masking responses of under-represented cell populations is increased when analyzing whole blood or PBMC. To investigate the contribution of individual cell types to the immune response after vaccination, we established a rapid and efficient method to purify human T and B cells, natural killer (NK) cells, myeloid dendritic cells (mDC), monocytes, and neutrophils from fresh venous blood. Purified cells were fractionated and processed in a single day. RNA-Seq and quantitative shotgun proteomics were performed to determine expression profiles for each cell type prior to and after inactivated seasonal influenza vaccination. Our results show that transcriptomic and proteomic profiles generated from purified immune cells differ significantly from PBMC. Differential expression analysis for each immune cell type also shows unique transcriptomic and proteomic expression profiles as well as changing biological networks at early time points after vaccination. This cell type-specific information provides a more comprehensive approach to monitor vaccine responses.

Indexed as

Systems BiologyBloodHumansInfluenza VaccinesProteomeSeasonsTranscriptomeInfluenza VaccinesProteome

Identifiers

PMID25706537
PMCPMC4338067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.